Our Cancer Research Grants | V Foundation

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded.

Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help men, women and children diagnosed with cancer.

Featured Grants

Gelareh Zadeh, MD, PhD, FRCS(C)

Building Algorithms to Predict Response to Radiation in Meningiomas using T...

Xiao-Nan Li, M.D., Ph.D.

Targeting Root Cells of Therapy Resistance in Pediatric Diffuse High-Grade ...

David Langenau, PhD

Reversing therapy resistance in pediatric rhabdomyosarcoma

Daniel Herranz, PharmD, PhD

Unleashing the therapeutic potential of dietary histidine restriction in T-ALL

Patrick Grohar, MD, PhD

Mechanisms of Resistance for EWS-FLI1 Targeted Therapies

Kelsey Bertrand, MSc, MD

Evaluating cellular immunotherapy as an effective treatment for high-risk p...

Scott Armstrong, MD, PhD

Targeting Menin Inhibitor Resistance in Pediatric Leukemia

Alejandro Gutierrez, MD

Developing Clinical GSK3a Inhibitors to Reverse Asparaginase Resistance in ...

Poulikos Poulikakos, PhD

Rational combination strategies to overcome therapeutic resistance to RAS p...

George Weiner, MD

T cell help and resistance to anti-cancer monoclonal antibody therapy

David Schlaepfer, PhD

Overcoming Ovarian Cancer Immune Resistance

Jonathan Peled, MD, PhD

Overcoming therapeutic resistance in myeloma: microbiome metabolites to aug...

David Oh, MD, PhD

Therapeutic modulation of cytotoxic CD4+ T cells via KLRG1 to overcome prim...

Roger Lo, MD, PhD

Blocking Genomic Instability to Prevent Acquired Resistance

Maayan Levy, PhD & Bryson Katona, MD PhD

Colorectal cancer interception in familial adenomatous polyposis through be...

Paul Dent, Ph.D., Steven Grant, M.D., John Roberts, M.D.

Combined proteasome and cyclin-dependent kinase inhibition: A novel therape...

Amar Gajjar, M.D., Richard J. Gilbertson, M.D., Ph.D., Helen Poppleton, Ph.D.

The Role of ERBB2 signaling in pediatric medulloblastoma

Queen of the Valley Hospital

Peter Albertsen, M.D. ; Pamela Taxel, M.D.

The potential role of estrogen on the inhibition of both Osteoclastogenesis...

Lynne Bemis, Ph.D.

The development and introduction of rational, molecular-based therapy for h...

Andrew Krivoshik, M.D., Ph.D.

Paul Meyers, M.D.

James M. Ford, M.D., Sylvia Plevritis, Ph.D.

Determinants of genomic instability in women with BRCA1 mutations undergoin...

Linzhao Cheng, Ph.D., Hyam I. Levitsky, M.D., Martin G. Pomper, M.D. , Ph.D. Richard Wahl, M.D.

In Vivo Imaging for Hematopoietic Cell Therapies

Ricardo C.T. Aguiar, M.D., Ph.D.

Validate the potential role of a gene named PDE4B in the development and pr...

Gabriele Bergers, Ph.D.

Identification of mechanisms and factors implicated in angiogenesis during ...

Fred Bunz, M.D., Ph.D.

Genetic determinants of therapeutic sensitivity in colon cancer cells: the ...

Arul M. Chinnaiyan, M.D., Ph.D.

Transcriptome analysis of breast and prostate cancer reveals connections to...

Frank B. Furnari, Ph.D.

Analysis of receptor tyrosine kinase signaling impingement on PTEN function...

Denis C. Guttridge, Ph.D.

Cancer Cachexia, A debilitating metabolic disorder characterized by extreme...

◂ 1 … 71 72 73 74 75 … 84 ▸

Mailing List